Conditions
Menin protein loss drives aging, reversed in mice
Research in mice suggests a brain protein's decline accelerates aging, while a separate trial explores accelerated magnetic stimulation for methamphetamine use disorder.
Conditions
Conditions on Mind and Margin: generalised, social, panic, phobias, major depressive disorder and persistent.
Conditions
Blocking P2X7 Receptor Reduces Neuroinflammation in Human Brain Tissue
University of Birmingham scientists have demonstrated that blocking the P2X7 receptor significantly reduces inflammatory responses in living human brain tissue, offering a new therapeutic strategy for conditions like traumatic brain injury, Alzheimer's, Parkinson's, and depression.
Conditions
Autism Life Expectancy in Medicaid Study 14 Years Shorter
A major study finds Medicaid beneficiaries with autism have a life expectancy of 64.9 years, nearly 14 years shorter than the general U.S.
Conditions
Amygdalostriatal transition zone identified in prolonged threat response
Neuroscientists have pinpointed a small brain region, the amygdalostriatal transition zone (ASt), that maintains neural activity for the full duration of a threat cue.
Conditions
Older Adults' Risk of Major Drug Interactions Falls, Study Finds
A new study shows the proportion of older Americans at risk for major drug interactions fell from 25.7% to 22.3% between 2015-2016 and 2021-2023.
Conditions
Amyloid Protein Predicts Brain Atrophy Before Dementia
A large study finds amyloid-beta accumulation in cognitively healthy older adults predicts future brain shrinkage.
Conditions
Meta's $17.1 Billion Settlement Creates Social Media Research Opportunity
Meta's settlement over youth safety on Facebook and Instagram introduces new platform design changes.
Conditions
Social Media Posts Push Alzheimer's Blood Tests Against Guidelines
Over a third of social media posts promote Alzheimer's blood tests for symptom-free people, contradicting clinical guidelines.
Conditions
New study links gene, lipid signaling to bipolar disorder
A new study identifies a molecular pathway involving the gene Serinc2 and membrane lipids that may explain differences between bipolar I and bipolar II disorder.
Conditions
Gabapentin Use Spiked After Michigan Descheduled Drug
A study in JAMA Network Open found gabapentin dispensing to Michigan Medicaid patients rose immediately after the state removed it from its controlled substance schedule.
Conditions
NIH Study: Ozempic Ingredient Slows Aging in Mice
Semaglutide, the active ingredient in Ozempic and Wegovy, extended lifespan and improved markers of aging in healthy older mice.
Conditions
Persistent Financial Hardship Linked to Faster Brain Aging
A UCL study finds that years of financial strain in early and middle adulthood are associated with poorer thinking skills by age 53.
Conditions
Neurons Control Brain Wiring Insulation
Harvard biologists have identified molecular signals that allow different types of neurons to control how their wiring is insulated with myelin.
Conditions
Walkable Neighborhoods May Lower Diabetes Risk
A Columbia University study finds women with prior gestational diabetes had a lower risk of developing type 2 diabetes if they lived in more walkable neighborhoods.
Conditions
Study: Physical Exams Unreliable for Child Pneumonia
A national study published in August 2026 found that doctors often disagree on lung sounds when examining children for pneumonia.
Conditions
Americans Seek IVF Abroad as U.S. Costs Soar
Americans are traveling to countries like Greece for cheaper IVF treatments, as U.S. costs can exceed $29,000 per cycle, despite experts warning of risks.
Conditions
Trump Picks New FDA Commissioner Amid Controversy
President Trump has nominated Heidi Overton, a top White House aide, to lead the FDA. The nomination has sparked controversy, with some critics questioning her qualifications and stance on abortion and vaccination.
Conditions
Regeneron's Pasatru Approved by FDA for Rare Bone Growth Disorder
The FDA has approved Regeneron's Pasatru for fibrodysplasia ossificans progressiva (FOP), a rare condition causing abnormal bone growth. The drug aims to slow disease progression, potentially preserving mobility and extending lifespan for patients who often rely on wheelchairs by age 25.
Conditions
Enduring NMDA Receptor Encephalitis: A Complex Condition
Researchers have made significant progress in understanding N-methyl-D-aspartate receptor (NMDAR) encephalitis, a condition characterized by widespread neuropsychiatric symptoms. A recent study has shed light on the structural brain changes and clinical outcomes of patients with NMDA receptor encephalitis in Germany.